Dongwha Pharm.Co.Ltd (000020) — Cash Flow Reinvestment Rate
Dongwha Pharm.Co.Ltd (000020) has a Cash Flow Reinvestment Rate of 0.93x as of December 2025, reinvesting ₩9.05 Billion (capex ₩7.06 Billion plus investments ₩1.99 Billion) from operating cash flow of ₩9.70 Billion. Explore Dongwha Pharm.Co.Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongwha Pharm.Co.Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Dongwha Pharm.Co.Ltd across 12 annual periods. Also explore how large is Dongwha Pharm.Co.Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Dongwha Pharm.Co.Ltd. For live market cap and broader valuation context, see Dongwha Pharm.Co.Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.81x | ₩59.79 Billion | ₩15.70 Billion | ₩55.30 Billion | ▲ +280.3% |
| 2023 | 1.00x | ₩29.21 Billion | ₩29.17 Billion | ₩26.35 Billion | ▼ -37.7% |
| 2022 | 1.61x | ₩47.00 Billion | ₩29.22 Billion | ₩18.43 Billion | ▲ +144.1% |
| 2021 | 0.66x | ₩23.74 Billion | ₩36.03 Billion | ₩21.94 Billion | ▼ -29.9% |
| 2020 | 0.94x | ₩49.13 Billion | ₩52.23 Billion | ₩34.25 Billion | ▲ +20.0% |
| 2019 | 0.78x | ₩10.42 Billion | ₩13.28 Billion | ₩4.80 Billion | ▼ -39.3% |
| 2016 | 1.29x | ₩32.93 Billion | ₩25.48 Billion | ₩2.50 Billion | ▲ +2332.7% |
| 2015 | 0.05x | ₩1.05 Billion | ₩19.83 Billion | ₩885.50 Million | ▼ -83.2% |
| 2014 | 0.32x | ₩4.28 Billion | ₩13.51 Billion | ₩1.28 Billion | ▼ -84.0% |
| 2013 | 1.98x | ₩16.24 Billion | ₩8.21 Billion | ₩3.24 Billion | ▲ +142.7% |
| 2012 | 0.82x | ₩20.58 Billion | ₩25.23 Billion | ₩6.48 Billion | ▲ +305.1% |
| 2011 | 0.20x | ₩9.31 Billion | ₩46.24 Billion | ₩9.15 Billion | — |